Cancer, Myeloma, Geriatric Oncology, Malignant Hematology, Plasma cell disorders, multiple myeloma, amyloidosis, senior/geriatric oncology, monoclonal gammopathy of uncertain significance (MGUS)
Bachelor of Science, and Bachelor of Arts: Tufts University, 1992-1996; MD: Georgetown University School of Medicine, 1998 – 2003; Resident and Chief Resident: Duke University Medical Center, 2003-2008; Fellow: Duke Cancer Institute, 2006-2010; Master’s Degree in Health Sciences: Duke University School of Medicine, 2008 – 2016; Assistant Professor: Duke Cancer Institute, 2013-2016; Associate Professor of Medicine: University of North Carolina at Chapel Hill, 2016-Present.
I am an expert in managing patients with multiple myeloma, amyloidosis, and other plasma cell disorders. I have conducted NIH-supported lab research but now focuse my efforts on clinical research in 1) treating multiple myeloma in patients who are at high risk for toxicity due to advanced age or other medical problems; 2) developing novel drugs for treating all patients with multiple myeloma; and 3) optimizing management for amyloidosis. I am a member of international working groups that formulate guidelines for treating these disorders, and I have won multiple awards for teaching and research accomplishments.